VIA
MBX

Virtus Investment Advisers’s MBX Biosciences MBX Stock Holding History

Virtus Investment Advisers’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$273K Buy
9,131
+221
+2% +$7.52K 0.08% 297
2025
Q4 		$281K Sell
8,910
-1,704
-16% -$41.3K 0.08% 269
2025
Q3 		$186K Buy
10,614
+1,842
+21% +$24.6K 0.05% 263
2025
Q2 		$100K Buy
8,772
+766
+10% +$7.8K 0.03% 331
2025
Q1 		$59.1K Buy
+8,006
New +$84.6K 0.02% 462

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Virtus Investment Advisers's MBX Position: Q1 2026 in Review

Virtus Investment Advisers increased its MBX Biosciences (MBX) stake by 2.5% in Q1 2026, buying an estimated $7.52K and bringing the position to 9,131 shares worth $273K. The position accounts for 0.08% of the portfolio, ranked #297.

Virtus Investment Advisers first reported a position in MBX in Q1 2025 and has held it in 5 quarters since. The position peaked at $281K in Q4 2025. 157 funds tracked by Wall St. Rank hold MBX as of Q1 2026.

  • Virtus Investment Advisers held 9,131 shares of MBX Biosciences worth $273K as of Q1 2026.
  • Virtus Investment Advisers bought 221 MBX Biosciences shares in Q1 2026, an estimated $7.52K.
  • MBX Biosciences made up 0.08% of Virtus Investment Advisers's portfolio in Q1 2026, its #297 holding.
  • Virtus Investment Advisers first reported a position in MBX Biosciences in Q1 2025 and has held it in 5 quarters since.
  • Virtus Investment Advisers's MBX Biosciences position peaked at $281K in Q4 2025.
  • 157 funds tracked by Wall St. Rank held MBX Biosciences as of Q1 2026.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.